 In a previous study, now accepted for publication in a leading diabetes journal, Diabetes Care, we have demonstrated, using continuous glucose monitoring system, that there is no significant difference in glucose concentrations ie. high and low blood glucose episodes when insulin Glargine is administered either mixed with a short-acting insulin analog or when giving it as a separate injection. 